SCN5A Variant P119T
Summary of observed carriers, functional annotations, and structural context for SCN5A P119T. Data combine curated literature, international cohorts, and gnomAD observations.
Estimated LQT3 penetrance
6%
0/10 effective observations
Estimated BrS1 penetrance
14%
1/10 effective observations
Total carriers
0
0 BrS1 · 0 LQT3 · 0 unaffected
Variant features alone are equivalent to phenotyping 1 individuals for Brugada syndrome and 0 individuals for LQT3.
In silico predictors
| PROVEAN | PolyPhen-2 | BLAST-PSSM | REVEL | Penetrance Density BrS (%) | Penetrance Density LQT3 (%) |
|---|---|---|---|---|---|
| NA | NA | NA | 0.806 | 11 | 4 |
PROVEAN scores below -2 suggest deleterious impact. REVEL scores above 0.5–0.75 are often interpreted as likely pathogenic. PolyPhen-2 scores above 0.85 are typically pathogenic. Penetrance density summarises neighbouring residue risk (Kroncke et al. 2019).
Reported carrier data
| Source | Year | Carriers | Unaffected | LQT3 | BrS1 | Other | Other Disease |
|---|---|---|---|---|---|---|---|
| Literature, cohort, and gnomAD | – | 0 | 0 | 0 | 0 | – | |
| Variant features alone | – | 15 | 14 | 0 | 1 | – | – |
Totals may differ from individual publications due to duplicate patients removed during curation.
Nearby variants
Neighbouring residues within 15 Ångström provide structural context. Variants listed in the right-most column have been observed clinically or in gnomAD.
| Neighbour residue | Distance (Å) | Observed variants |
|---|---|---|
| 126 | 10 | K126E, |
| 178 | 12 | A178G, |
| 117 | 8 | |
| 119 | 0 | P119S, P119L, |
| 179 | 14 | R179X, R179Q, |
| 177 | 11 | L177P, |
| 123 | 7 | A123G, A123V, |
| 121 | 7 | R121W, R121Q, |
| 127 | 13 | |
| 124 | 9 | A124D, |
| 118 | 5 | |
| 125 | 10 | V125L, V125L, |
| 174 | 14 | V174I, |
| 115 | 9 | S115G, |
| 112 | 15 | Y112C, |
| 114 | 12 | |
| 116 | 9 | |
| 180 | 15 | G180V |
| 120 | 4 | |
| 122 | 5 |